Objective: The aim of this work was to evaluate receptive and expressive language skills in children with congenital hypothyroidism receiving early hormonal replacement treatment before the age of 3 months and to identify any subtle areas of weaknesses in their language development to check the necessity for future language intervention. Patients and Methods: The study was conducted on 30 hypothyroid children receiving hormonal replacement. They were subdivided into group I (5-8 years 11 months; 12 cases) and group II (9-12 years 11 months; 18 cases). All patients were subjected to a protocol of assessment applied in the Diabetes, Endocrine and Metabolism Pediatric Unit (DEMPU) and evaluation of language skills by the REAL scale. Results: The younger group reached average Arabic language scores, while the older group showed moderate language delay. Conclusion: Early replacement therapy supports language development in young children. However, longitudinal and follow-up studies are required to identify difficulties presenting at older ages that may affect children in the academic settings.

Keywords:
Congenital hypothyroidism, Hormonal replacement, Language development
1.
Fisher DA: Disorders of the thyroid in the newborn and infant; in Sperling MA: Pediatric Endocrinology, ed 3. Philadelphia, W.B. Saunders, 2008, 198-226.
2.
Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Maternal-fetal thyroid hormone relationships and the fetal brain. Acta Med Austriaca 1988;15:66-70.
3.
Klein AH, Meltzer S, Kenny FM: Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr 1972;81:912-915.
4.
Alves C, Eidson M, Engle H, Sheldon J, Cleveland MM: Changes in brain maturation detected by magnetic resonance imaging in congenital hypothyroidism. J Pediatr 1989;115:600-603.
5.
Bhatia V, Poptani H, Gupta RK, Gujral RB: MRI of the brain in sporadic congenital hypothyroidism (SCH) and endemic iodine deficiency cretinism. Pediatr Res 1993;33(suppl): 593.
6.
Siragusa V, Boffelli S, Weber G: Brain magnetic resonance imaging in congenital hypothyroid infants at diagnosis. Thyroid 1997;7:761-764.
7.
Fisher DA, Lehman H, Lackey C: Placental transport of thyroxine. J Clin Endocrinol Metab 1964;24:393-400.
8.
Bargagna S, Canepa G, Costagli C, Dinetti D, Marcheschi M, Millepiedi S: Neuropsychological follow-up in early-treated congenital hypothyroidism: a problem-oriented approach. Thyroid 2000;10:243-249.
9.
Dugbartey AT: Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998;158:1413-1418.
10.
Smith DW, Blizzard RM, Wilkins L: The mental prognosis in hypothyroidism. Pediatrics 1957;19:1011-1022.
11.
Thorndik RL, Hagen EP, Satter JM: The Stanford-Binet Intelligence Scale, ed 4. Itasca, Riverside Publishing, 1986.
12.
Osman DA: REAL Scale (Receptive Expressive Arabic Language Scale). Cairo, Print House, 2014.
13.
Dugbartey AT: Neurocognitive Aspects of hypothyroidism. Arch Intern Med 1998;158:1413-1418.
14.
Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM: Psychological well-being in patients on ‘adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol 2002;57:577-585
15.
Gathercole SE, Service E, Hitch GJ, Adams AM, Martin A: Phonological short term memory and vocabulary development. Future evidence on the nature of relationship. Appl Cogn Psychol 1999;13:56-77.
16.
Kooistra L ,Van der Meere JJ, Vulsma T, Kalverboer A F: Sustained attention problems in children with early-treated congential hypothyroidism. Acta Paediatr 1996;85425-85429.
17.
Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD, Hershman JM, Cummings JL, Tourtellotte WW, Solomon DH: Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992;40:325-335.
18.
Burmeister LA, Ganguli M, Dodge HH, Toczek T, DeKosky ST, Nebes RD: Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. Thyroid 2001;11:1177-1185.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.